Clinics in Dermatology
Volume 25, Issue 1 , Pages 56-62 , January 2007

The hormonal regulation of cutaneous wound healing

References 

  1. Vaughan MB, Howard EW, Tomasek JJ. Transforming growth factor–β1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res. 2000;257:180–189
  2. Ashcroft GS, Horan MA, Ferguson MW. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest. 1998;78:47–58
  3. Ashcroft GS, Horan MA, Herrick SE, et al. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res. 1997;290:581–585
  4. Ashcroft GS, Horan MA, Ferguson MW. Ageing is associated with reduced deposition of specific extracellular matrix components, an up-regulation of angiogenesis, and an altered inflammatory response in a murine incisional wound healing model. J Invest Dermatol. 1997;108:430–437
  5. Arvat E, Di Vito L, Lanfranco F, et al. Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. J Clin Endocrinol Metab. 2000;85:3141–3146
  6. Ashcroft GS, Dodsworth J, van Boxtel E, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nat Med. 1997;3:1209–1215
  7. Ashcroft GS, Greenwell-Wild T, Horan MA, et al. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol. 1999;155:1137–1146
  8. Mills SJ, Ashworth JJ, Gilliver SC, et al. The sex steroid precursor DHEA accelerates cutaneous wound healing via the estrogen receptors. J Invest Dermatol. 2005;125:1053–1062
  9. Ashcroft GS, Mills SJ. Androgen receptor mediated inhibition of cutaneous wound healing. J Clin Invest. 2002;110:615–624
  10. Labrie F, Luu-The V, Labrie C, et al. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol. 2001;22:185–212
  11. Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 1994;130:489–493
  12. Phillips TJ. Chronic cutaneous ulcers: etiology and epidemiology. J Invest Dermatol. 1994;102:38–41
  13. Callam MJ, Ruckley CV, Harper DR, et al. Chronic ulceration of the leg: extent of the problem and provision of care. Br Med J (Clin Res Ed). 1985;290:1855–1856
  14. Taylor RJ, Taylor AD, Smyth JV. Using an artificial network to predict healing times and risk factors for venous leg ulcers. J Wound Care. 2002;11:101–105
  15. Berard A, Kahn SR, Abenhaim L. Is hormone replacement therapy protective for venous ulcer of the lower limbs?. Pharmacoepidemiol Drug Saf. 2001;10:245–251
  16. Margolis DJ, Knauss J, Bilker W. Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers. Lancet. 2002;359:675–677
  17. Ashcroft GS, Mills SJ, Lei K, et al. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest. 2003;111:1309–1318
  18. Ashcroft GS, Mills SJ, Flanders KC, et al. Role of Smad3 in the hormonal modulation of in vivo wound healing responses. Wound Repair Regen. 2003;11:468–473
  19. Herrick S, Ashcroft G, Ireland G, et al. Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers is associated with matrix degradation. Lab Invest. 1997;77:281–288
  20. Ashcroft GS, Yang X, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol. 1999;1:260–266
  21. Baumann R, Casaulta C, Simon D, et al. Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondrial-dependent death pathway. FASEB J. 2003;17:2221–2230
  22. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3:791–800
  23. Nishihira J, Koyama Y, Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine. 1998;10:199–205
  24. Hardman MJ, Waite A, Zeef L, et al. Macrophage migration inhibitory factor: a central regulator of wound healing. Am J Pathol. 2005;167:1561–1574
  25. Kanda N, Watanabe S. 17β-estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression. J Invest Dermatol. 2004;123:319–328
  26. Kanda N, Watanabe S. 17β-estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression. J Invest Dermatol. 2003;121:1500–1509
  27. Morales DE, McGowan KA, Grant DS, et al. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation. 1995;91:755–763
  28. Calvin M. Oestrogens and wound healing. Maturitas. 2000;34:195–210
  29. Shanker G, Sorci-Thomas M, Adams MR. Estrogen modulates the inducible expression of platelet-derived growth factor mRNA by monocytes/macrophages. Life Sci. 1995;56:499–507
  30. Katz MH, Alvarez AF, Kirsner RS, et al. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Am Acad Dermatol. 1991;25:1054–1058
  31. Rappolee DA, Mark D, Banda MJ, et al. Wound macrophages express TGFα and other growth factors in vivo: analysis by mRNA phenotyping. Science. 1988;241:708–712
  32. Grande JP. Role of TGF-β in tissue injury and repair. Proc Soc Exp Biol Med. 1997;214:27–40
  33. Beck LS, de Guzman L, Lee WP, et al. One systemic administration of TGF-β1 reverses age- or glucocorticoid- impaired wound healing. J Clin Invest. 1993;92:2841–2849
  34. Ashworth JJ, Smyth JV, Pendleton N, et al. The dinucleotide (CA) repeat polymorphism of estrogen receptor beta but not the dinucleotide (TA) repeat polymorphism of estrogen receptor alpha is associated with venous ulceration. J Steroid Biochem Mol Biol. 2005;97:266–270
  35. Baker AE, Brautigam VM, Watters JJ. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor β. Endocrinology. 2004;145:5021–5032
  36. Carswell HV, Macrae IM, Gallagher L, et al. Neuroprotection by a selective estrogen receptor β agonist in a mouse model of global ischemia. Am J Physiol Heart Circ Physiol. 2004;287:1501–1504
  37. Gabel SA, Walker VR, London RE, et al. Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol. 2005;38:289–297
  38. Harris HA, Albert LM, Leathurby Y, et al. Evaluation of an estrogen receptor–β agonist in animal models of human disease. Endocrinology. 2003;144:4241–4249
  39. Araneo BA, Ryu SY, Barton S, et al. Dehydroepiandrosterone reduces progressive dermal ischemia caused by thermal injury. J Surg Res. 1995;59:250–262
  40. Padgett DA, Loria RM. Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol. J Neuroimmunol. 1998;84:61–68
  41. Shin MH, Rhie GE, Park CH, et al. Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin. J Invest Dermatol. 2005;124:315–323
  42. Holt DR, Kirk SJ, Regan MC, et al. Effect of age on wound healing in healthy human beings. Surgery. 1992;112:293–297
  43. Ballas CB, Davidson JM. Delayed wound healing in aged rats is associated with increased collagen gel remodeling and contraction by skin fibroblasts, not with differences in apoptotic or myofibroblast cell populations. Wound Rep Reg. 2001;9:223–227
  44. Gray A, Feldman HA, McKinlay JB, et al. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991;73:1016–1025
  45. Punjabi U, Deslypere JP, Verdonck L, et al. Androgen and precursor levels in serum and testes of adult rats under basal conditions and after hCG stimulation. J Steroid Biochem. 1983;19:1481–1490
  46. Gilliver SC, Ashworth JJ, Mills SJ, et al. Androgens modulate the inflammatory response during acute wound healing. J Cell Sci. 2006;119:722–732
  47. Yao J, Mackman N, Edgington TS, et al. Lipopolysaccharide induction of the tumor necrosis factor–α promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-κB transcription factors. J Biol Chem. 1997;272:17795–17801
  48. Kurokouchi K, Kambe F, Yasukawa K, et al. TNF-α increases expression of IL-6 and ICAM-1 genes through activation of NF-κB in osteoblast-like ROS17/2.8 cells. J Bone Miner Res. 1998;13:1290–1299
  49. Li ZG, Danis VA, Brooks PM. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol. 1993;11:157–162
  50. Posma E, Moes H, Heineman MJ, et al. The effect of testosterone on cytokine production in the specific and non-specific immune response. Am J Reprod Immunol. 2004;52:237–243
  51. Kanda N, Tsuchida T, Tamaki K. Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol. 1996;106:410–415
  52. Schierle HP, Scholz D, Lemperle G. Elevated levels of testosterone receptors in keloid tissue: an experimental investigation. Plast Reconstr Surg. 1997;100:390–395
  53. Ford LC, King DF, Lagasse LD, et al. Increased androgen binding in keloids: a preliminary communication. J Dermatol Surg Oncol. 1983;9:545–547

PII: S0738-081X(06)00143-X

doi: 10.1016/j.clindermatol.2006.09.012

Clinics in Dermatology
Volume 25, Issue 1 , Pages 56-62 , January 2007

Article Tools

* Image Usage & Resolution